Alimera Sciences Refinances Debt Facility With Solar Capital

- January 6th, 2020

Alimera announced it has entered into a new US$45 million term loan agreement with investment affiliates managed by Solar Capital Partners.

Alimera Sciences (NASDAQ:ALIM) announced that it refinanced its debt facility by entering into a new US$45 million term loan agreement with investment affiliates managed by Solar Capital Partners.

As quoted in the press release:

The amount of the new funding includes an initial tranche of $42.5 million used to repay the current facility, including principal, prepayment fees and accrued interest, and another $2.5 million tranche that will be available if Alimera achieves $30.0 million in revenue for any trailing six-month period ending on or before November 30, 2020.

The new loan agreement has a term of 54 months to July 1, 2024, with monthly interest-only payments to January 1, 2023, when principal amortization begins. The interest-only period may be extended an additional six months if Alimera achieves $34.5 million in revenue for any trailing six-month period ending on or before June 30, 2022.

Click here to read the full press release.

Find out what experts are saying about the future of cannabis

 
Read our new report today
 

Get the latest Biotech Investing stock information

Get the latest information about companies associated with Biotech Investing Delivered directly to your inbox.

Biotech Investing

Select None
Select All